LPCN
Lipocine
$1.52
+$0.01 (+0.66%)Oct 29, 2026
Key metrics
The numbers that frame LPCN today
- Market cap
- $12.53M
- Gross margin
- 100%
- EV / Sales
- 4.8
- ROIC
- -87.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.40
- 52wk High
- $12.37
Growth
Revenue and earnings trend for LPCN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LPCN
Is Lipocine a good buy?
No. Lipocine has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Lipocine is selling at a very high price.
What is the market capitalization of LPCN?
Lipocine's market capitalization is $12.53M.
What is the 52-week high for LPCN stock?
The 52-week high for Lipocine is $12.37. The current close of $1.52 is 87.7% below that high.
What is the 52-week low for LPCN stock?
The 52-week low for Lipocine is $1.40. The current close of $1.52 is 8.6% above that low.
Does LPCN stock pay dividends?
Lipocine does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LPCN?
Lipocine's Debt / Equity ratio is 0.